Cadherins E and P expression in the molecular types of breast cancer

被引:0
作者
Fernandez, Angel
Reigosa, Aldo
Caleiras, Eduardo [1 ]
Saldivia, Felipe [2 ]
Hardisson, David [3 ]
Sanz, Francisco [4 ]
机构
[1] Hosp Metropolitano Norte, Unidad Diagnost Anatomopatol, Valencia, Venezuela
[2] Inst Oncol Dr Miguel Perez Carreno, Valencia, Venezuela
[3] Univ Autonoma Madrid, Fac Med, Dept Anat Patol, E-28049 Madrid, Spain
[4] Univ Autonoma Madrid, Fac Ciencias, Dept Biol, E-28049 Madrid, Spain
来源
INVESTIGACION CLINICA | 2015年 / 56卷 / 02期
关键词
cadherin E; cadherin P; molecular class; epithelial-mesenchymal transition; breast cancer; EPITHELIAL-MESENCHYMAL TRANSITION; BASAL-LIKE PHENOTYPE; ESTROGEN-RECEPTOR; TUMOR PROGRESSION; STEM-CELLS; SUBTYPES; CARCINOMA; THERAPY; PROGNOSIS; SURVIVAL;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The epithelial-mesenchymal transition is a process by which tumor cells lose their epithelial markers and migrate to distant organs. This process involves several cell adhesion proteins such as E-cadherin and P-cadherin. The present study was performed in 354 pacients diagnosed with breast infiltrating ductal carcinoma in the Oncology Institute "Dr. Miguel Perez Carrerno", Valencia, Venezuela. The expression of 22 molecules was analyzed by tissue micro-arrays and the results were compared with the molecular clases established by immunohistochemistry, according to the expression of estrogen receptor (ER), progesterone (PR) and human epidermal growth factor receptor type 2 (HER2), and with the overall survival (OS). Based on the results of ER, PR and HER2 molecular classes according to the following percentages were established: Luminal A 42.4%, Luminal B 20.3%, 9% HER2 and 28.2% triple negative (TN). E-cadherin expression was observed conserved in most of the tumors of this series, 92.5% of cases. TN phenotype tumors showed a high percentage (41.7%) with absent or reduced expression. The P-cadherin was expressed in 40.5% of cases, although expressed in all classes; the proportion was significantly higher in cases TN. No significant prognostic value was observed when analyzing the overall five-year survival of patients with tumors with absent or reduced expression of E-cadherin. The P-cadherin expression had a negative relationship with the OS.
引用
收藏
页码:155 / 168
页数:14
相关论文
共 50 条
[41]   Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes [J].
Erber, Ramona ;
Kailayangiri, Sareetha ;
Huebner, Hanna ;
Ruebner, Matthias ;
Hartmann, Arndt ;
Haeberle, Lothar ;
Meyer, Julia ;
Voelkl, Simon ;
Mackensen, Andreas ;
Landgraf, Laura ;
Geppert, Carol, I ;
Schulz-Wendtland, Ruediger ;
Beckmann, Matthias W. ;
Fasching, Peter A. ;
Farwick, Nicole ;
Rossig, Claudia ;
Gass, Paul .
CANCERS, 2021, 13 (21)
[42]   Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer [J].
Morrison, D. H. ;
Rahardja, D. ;
King, E. ;
Peng, Y. ;
Sarode, V. R. .
BRITISH JOURNAL OF CANCER, 2012, 107 (02) :382-387
[43]   Glutathione transferase pi (GSTpi) expression in breast cancer: An immunohistochemical and molecular study [J].
Jardim, Bruna Victorasso ;
Moschetta, Marina Gobbe ;
Gelaleti, Gabriela Bottaro ;
Leonel, Camila ;
Regiani, Vitor Rafael ;
Neto, Dalisio de Santi ;
Bordin-Junior, Newton A. ;
Perea, Silvia Aparecida ;
Pires de Campos Zuccari, Debora Ap .
ACTA HISTOCHEMICA, 2012, 114 (05) :510-517
[44]   Baseline staging tests based on molecular subtype is necessary for newly diagnosed breast cancer [J].
Chen, Xuesong ;
Sun, Lichun ;
Cong, Yingying ;
Zhang, Tingting ;
Lin, Qiushi ;
Meng, Qingwei ;
Pang, Hui ;
Zhao, Yanbin ;
Li, Yu ;
Cai, Li ;
Dong, Xiaoqun .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2014, 33
[45]   Evaluation of the pathological response and prognosis following neoadjuvant chemotherapy in molecular subtypes of breast cancer [J].
Zhao, Yue ;
Dong, Xiaoqiu ;
Li, Rongguo ;
Ma, Xiao ;
Song, Jian ;
Li, Yingjie ;
Zhang, Dongwei .
ONCOTARGETS AND THERAPY, 2015, 8 :1511-1521
[46]   Therapeutic Targeting of the Galectin-1/miR-22-3p Axis Regulates Cell Cycle and EMT Depending on the Molecular Subtype of Breast Cancer [J].
Kim, Ju Yeon ;
Lee, Jun Ho ;
Jung, Eun Jung ;
Son, Young Sim ;
Park, Hee Jin ;
Kim, Jae Myung ;
Park, Taejin ;
Jeong, Sang-Ho ;
Lee, Jinkwon ;
Kim, Tae Han ;
Lee, Seon Min ;
Heo, Jeong Doo .
CELLS, 2025, 14 (04)
[47]   Significance of p85 expression as a prognostic factor for patients with breast cancer [J].
Zhou, Weiwei ;
An, Guangyu ;
Wei, Ping ;
Chen, Wenming .
ONCOLOGY LETTERS, 2014, 8 (04) :1657-1661
[48]   miR-410-3p suppresses breast cancer progression by targeting Snail [J].
Zhang, Ya-Feng ;
Yu, Yue ;
Song, Wang-Zhao ;
Zhang, Rui-Ming ;
Jin, Shan ;
Bai, Jun-Wen ;
Kang, Hong-Bin ;
Wang, Xin ;
Cao, Xu-Chen .
ONCOLOGY REPORTS, 2016, 36 (01) :480-486
[49]   Characterization of β2-microglobulin expression in different types of breast cancer [J].
Li, Kesheng ;
Du, Huifen ;
Lian, Xiaowen ;
Yang, Suisheng ;
Chai, Dandan ;
Wang, Chunya ;
Yang, Rong ;
Chen, Xuezhong .
BMC CANCER, 2014, 14
[50]   Molecular aspects of breast cancer resistance to drugs (Review) [J].
Calaf, Gloria M. ;
Zepeda, Andrea B. ;
Castillo, Rodrigo L. ;
Figueroa, Carolina A. ;
Arias, Consuelo ;
Figueroa, Elias ;
Farias, Jorge G. .
INTERNATIONAL JOURNAL OF ONCOLOGY, 2015, 47 (02) :437-445